無料セミナー : 2019年11月19日『手術用ロボット:外科医療におけるトランスフォーメーション』 BIS Research共同開催

株式会社グローバルインフォメーション
TEL: 044-952-0102
市場調査レポート

電子処方箋の世界市場:考察、機会、分析、市場シェア、将来予測

Global E-Prescribing Market Insights, Opportunity Analysis, Market Shares and Forecast 2017 - 2023

発行 Occams Business Research & Consulting Pvt. Ltd. 商品コード 484636
出版日 ページ情報 英文 140 Pages
納期: お問合せ
価格
本日の銀行送金レート: 1USD=109.20円で換算しております。
Back to Top
電子処方箋の世界市場:考察、機会、分析、市場シェア、将来予測 Global E-Prescribing Market Insights, Opportunity Analysis, Market Shares and Forecast 2017 - 2023
出版日: 2017年03月27日 ページ情報: 英文 140 Pages
概要

当レポートでは、世界の電子処方箋の市場について分析し、技術・市場の概略や最新動向、主な市場促進・阻害要因、市場の機会・課題、提供方式別・エンドユーザー別・製品別および地域別の市場動向予測 (過去3年間・今後7年間分)、競合情勢、市場発展の方向性、主要企業のプロファイルなどを調査しております。

第1章 イントロダクション

第2章 市場概要

  • 世界の電子処方箋市場:発展と遷移
  • 産業構造
  • 市場全体の分析
  • 市場推計分析
  • 戦略分析
    • 投資/導入モデル
    • 全方位的な産業分析
    • ポーターのファイブフォース分析
    • シーソー分析
    • 価格の分析
    • 消費者分析と主な購入基準
  • 市場競争分析
    • 市場シェア分析
    • 主要企業の分析
  • 戦略的提言と主な結論
    • 各地域での市場機会
    • 新規分野での市場機会
    • 急成長市場での投資機会

第3章 市場の決定要因

  • 市場促進要因とその影響
  • 市場抑制要因
  • 市場機会
  • 市場の課題

第4章 市場区分

  • 世界の電子処方箋市場:提供方式別
    • 市場の定義と範囲
    • 意思決定支援データベースおよび推計手法
    • 市場間の比較分析
    • 市場機会マトリックス
    • 市場区分:提供方式別
      • クラウド方式
      • オンプレミス方式
      • Web方式
  • 世界の電子処方箋市場:エンドユーザー別
    • 市場区分:エンドユーザー別
      • 病院
      • 薬局
      • クリニック
  • 世界の電子処方箋市場:製品別
    • 市場区分:製品別
      • ソリューション
      • サービス
      • アプリケーション

第5章 競争環境

  • 主な戦略
    • 企業合併・買収 (M&A) の一覧
    • 合弁事業 (JV) の一覧
    • 製品発売の一覧
    • 事業提携の一覧
  • 上位企業10社の分析

第6章 地域別分析

  • 意思決定支援データベースおよび推計手法
  • 市場間の比較分析
  • 市場機会マトリックス
  • 世界の電子処方箋市場:地域別
    • 北米市場
      • エンドユーザー別分析
      • 主要国市場の分析
    • 欧州市場
    • アジア太平洋地域市場
    • 他の国々 (RoW)

第7章 企業プロファイル

目次
Product Code: HHE-4780417

The global e-prescribing market is expected to grow with the CAGR of approximately 21.2% during the forecast period. The market has been driven due to large number of factors such as implementation of EHR with E-Prescribing system, favorable government support to develop healthcare infrastructure, growing focus on patient convenience and decreasing medication errors and high focus on declining healthcare cost. Approximately, half of all healthcare costs come from hospital expenditure: around 30% from hospital inpatient and around 19% from hospital outpatient. Physicians hold for approx. 30% and prescription drugs approx. 17%. Thus, to reduce such cost e-prescribing is a better tool as it declines manual work and connects medical professionals with each other. Although, there are some hurdles in the market such as patient privacy & security issues and lack of high speed broadband services. Growing demand in emerging countries and increasing demand among physicians are offering better opportunity for the market growth in near future. However, lack of skilled professionals and high cost of the system are some major challenges in the market. Geographically, Europe occupies major share in e-prescribing market. The reason for its dominance is growing burden to reduce healthcare cost coupled with the growing chronic disease and aging population in the region. North America and Asia Pacific is also expected to grow high in near future with the growing government support to create better healthcare infrastructure. Moreover, the presence of major players such as IBM, GE Healthcare, Cerner Corporation, Athena Health Inc., QuadraMed etc. are offering high scope for more innovations in the market.

The global E-Prescribing market has been segmented on the basis of delivery model, end user and product. According to Product, the market is further categorized into solutions and services. Among Product segment, the solutions held major share in 2015. The increasing adoption of e-prescribing solutions coupled with government support by incentive programs. According to end user, the market is further categorized into hospitals, physicians and clinics. Among end user segment, hospitals held major share with the extensive demand for e-prescribing solutions in the hospitals of Europe and U.S. In addition, the Patient Protection and Affordable Care Act in the United States have attributed to the reorganization of Medicare, private insurance and Medicaid systems. For physicians, the CMS incentive program compensates physicians for utilizing EHR (Electronic Health Records), which is helpful to increase the use of such solutions among physicians. According to delivery model, the market is further categorized into Cloud based, On-premise and Web-based models. Among delivery model, web based and cloud based segment together held major share. It has been led due to growing demand for cloud-based solutions in order to increase the convenience to send patient records from distant locations and which ultimately develop workflow efficiency. In addition, it is also helpful to connect with IT staff in order to focus on highly critical tasks which increasing cost-efficiency and productivity of the organization.

TABLE OF CONTENTS

1. INTRODUCTION

  • 1.1. EXECUTIVE SUMMARY
  • 1.2. ESTIMATION METHODOLOGY

2. MARKET OVERVIEW

  • 2.1. GLOBAL E-PRESCRIBING MARKET: EVOLUTION & TRANSITION
  • 2.2. INDUSTRY STRUCTURE
  • 2.3. TOTAL MARKET ANALYSIS
    • 2.3.1. TOP 5 FINDINGS
    • 2.3.2. TOP 5 OPPORTUNITY MARKETS
    • 2.3.3. TOP 5 COMPANIES
    • 2.3.4. TOP 3 COMPETITIVE STRATEGIES
  • 2.4. ESTIMATION ANALYSIS
  • 2.5. STRATEGIC ANALYSIS
    • 2.5.1. INVESTMENT VS. ADOPTION MODEL
    • 2.5.2. 360 DEGREE INDUSTRY ANALYSIS
    • 2.5.3. PORTERS 5 FORCE MODEL
    • 2.5.4. SEE-SAW ANALYSIS
    • 2.5.5. CONSUMER ANALYSIS AND KEY BUYING CRITERIA
  • 2.6. COMPETITIVE ANALYSIS
    • 2.6.1. MARKET SHARE ANALYSIS
    • 2.6.2. TOP COMPANY ANALYSIS
  • 2.7. STRATEGIC RECOMMENDATIONS & KEY CONCLUSIONS
    • 2.7.1. INVESTMENT OPPORTUNITIES BY REGIONS
    • 2.7.2. OPPORTUNITIES IN EMERGING APPLICATIONS
    • 2.7.3. INVESTMENT OPPORTUNITY IN FASTEST GROWING SEGMENT

3. MARKET DETERMINANTS

  • 3.1. MARKET DRIVERS
    • 3.1.1. IMPLEMENTATION OF HER WITH E-PRESCRIBING SYSTEM
    • 3.1.2. GROWING FOCUS ON PATIENT CONVENIENCE AND DECREASING MEDICATION ERRORS.
    • 3.1.3. FAVORABLE GOVERNMENT SUPPORT TO DEVELOP HEALTHCARE INFRASTRUCTURE
    • 3.1.4. HIGH FOCUS ON DECLINING HEALTHCARE COST
  • 3.2. MARKET RESTRAINTS
    • 3.2.1. PATIENT PRIVACY & SECURITY ISSUES
    • 3.2.2. LACK OF HIGH SPEED BROADBAND SERVICES
  • 3.3. MARKET OPPORTUNITIES
    • 3.3.1. GROWING DEMAND IN EMERGING COUNTRIES
    • 3.3.2. INCREASING DEMAND AMONG PHYSICIANS
  • 3.4. MARKET CHALLENGES
    • 3.4.1. LACK OF SKILLED PROFESSIONALS
    • 3.4.2. HIGH COST OF THE SYSTEM.

4. MARKET SEGMENTATION

  • 4.1. GLOBAL E-PRESCRIBING MARKET BY DELIVERY MODEL
    • 4.1.1. MARKET DEFINITION AND SCOPE
    • 4.1.2. DECISION SUPPORT DATABASE & ESTIMATION METHODOLOGY
    • 4.1.3. COMPARATIVE ANALYSIS ACROSS MARKET SEGMENTS
    • 4.1.4. OPPORTUNITY MATRIX
    • 4.1.5. MARKET SEGMENTATION BY COMPONENT 2014-2023 ($ MILLION)
      • 4.1.5.1. GLOBAL E-PRESCRIBING MARKET BY CLOUD BASED
        • 4.1.5.1.1. APPLICATION
        • 4.1.5.1.2. ADOPTION SCENARIO & MARKET DETERMINANTS
        • 4.1.5.1.3. MARKET ESTIMATIONS AND FORECASTS 2014-2023 ($ MILLION)
        • 4.1.5.1.4. TOP PLAYERS & KEY PRODUCTS
        • 4.1.5.1.5. KEY CONCLUSIONS
      • 4.1.5.2. GLOBAL E-PRESCRIBING MARKET BY ON-PREMISE
        • 4.1.5.2.1. APPLICATION
        • 4.1.5.2.2. ADOPTION SCENARIO & MARKET DETERMINANTS
        • 4.1.5.2.3. MARKET ESTIMATIONS AND FORECASTS 2014-2023 ($ MILLION)
        • 4.1.5.2.4. TOP PLAYERS & KEY PRODUCTS
        • 4.1.5.2.5. KEY CONCLUSIONS
      • 4.1.5.3. GLOBAL E-PRESCRIBING MARKET BY WEB BASED
        • 4.1.5.3.1. APPLICATION
        • 4.1.5.3.2. ADOPTION SCENARIO & MARKET DETERMINANTS
        • 4.1.5.3.3. MARKET ESTIMATIONS AND FORECASTS 2014-2023 ($ MILLION)
        • 4.1.5.3.4. TOP PLAYERS & KEY PRODUCTS
        • 4.1.5.3.5. KEY CONCLUSIONS
  • 4.2. GLOBAL E-PRESCRIBING MARKET BY END USER
    • 4.2.1. MARKET DEFINITION AND SCOPE
    • 4.2.2. DECISION SUPPORT DATABASE & ESTIMATION METHODOLOGY
    • 4.2.3. COMPARATIVE ANALYSIS ACROSS MARKET SEGMENTS
    • 4.2.4. OPPORTUNITY MATRIX
    • 4.2.5. MARKET SEGMENTATION BY END USER 2014-2023 ($ MILLION)
      • 4.2.5.1. GLOBAL E-PRESCRIBING MARKET BY HOSPITALS
        • 4.2.5.1.1. APPLICATION
        • 4.2.5.1.2. ADOPTION SCENARIO & MARKET DETERMINANTS
        • 4.2.5.1.3. MARKET ESTIMATIONS AND FORECASTS 2014-2023 ($ MILLION)
        • 4.2.5.1.4. TOP PLAYERS & KEY PRODUCTS
        • 4.2.5.1.5. KEY CONCLUSIONS
      • 4.2.5.2. GLOBAL E-PRESCRIBING MARKET BY PHYSICIANS
        • 4.2.5.2.1. APPLICATION
        • 4.2.5.2.2. ADOPTION SCENARIO & MARKET DETERMINANTS
        • 4.2.5.2.3. MARKET ESTIMATIONS AND FORECASTS 2014-2023 ($ MILLION)
        • 4.2.5.2.4. TOP PLAYERS & KEY PRODUCTS
        • 4.2.5.2.5. KEY CONCLUSIONS
      • 4.2.5.3. GLOBAL E-PRESCRIBING MARKET BY CLINICS
        • 4.2.5.3.1. APPLICATION
        • 4.2.5.3.2. ADOPTION SCENARIO & MARKET DETERMINANTS
        • 4.2.5.3.3. MARKET ESTIMATIONS AND FORECASTS 2014-2023 ($ MILLION)
        • 4.2.5.3.4. TOP PLAYERS & KEY PRODUCTS
        • 4.2.5.3.5. KEY CONCLUSIONS
  • 4.3. GLOBAL E-PRESCRIBING MARKET BY PRODUCT
    • 4.3.1. MARKET DEFINITION AND SCOPE
    • 4.3.2. DECISION SUPPORT DATABASE & ESTIMATION METHODOLOGY
    • 4.3.3. COMPARATIVE ANALYSIS ACROSS MARKET SEGMENTS
    • 4.3.4. OPPORTUNITY MATRIX
    • 4.3.5. MARKET SEGMENTATION BY PRODUCT 2014-2023 ($ MILLION)
      • 4.3.5.1. GLOBAL E-PRESCRIBING MARKET BY SOLUTIONS
        • 4.3.5.1.1. APPLICATION
        • 4.3.5.1.2. ADOPTION SCENARIO & MARKET DETERMINANTS
        • 4.3.5.1.3. MARKET ESTIMATIONS AND FORECASTS 2014-2023 ($ MILLION)
        • 4.3.5.1.4. TOP PLAYERS & KEY PRODUCTS
        • 4.3.5.1.5. KEY CONCLUSIONS
      • 4.3.5.2. GLOBAL E-PRESCRIBING MARKET BY SERVICES
      • 4.3.5.3. APPLICATION
        • 4.3.5.3.1. ADOPTION SCENARIO & MARKET DETERMINANTS
        • 4.3.5.3.2. MARKET ESTIMATIONS AND FORECASTS 2014-2023 ($ MILLION)
        • 4.3.5.3.3. TOP PLAYERS & KEY PRODUCTS
        • 4.3.5.3.4. KEY CONCLUSIONS

5. COMPETITIVE LANDSCAPE

  • 5.1. KEY STRATEGIES
    • 5.1.1. LIST OF M&A
    • 5.1.2. LIST OF JV
    • 5.1.3. LIST OF PRODUCT LAUNCHES
    • 5.1.4. LIST OF PARTNERSHIP
  • 5.2. TOP 10 COMPANY ANALYSIS

6. GEOGRAPHICAL ANALYSIS

  • 6.1. DECISION SUPPORT DATABASE & ESTIMATION METHODOLOGY
  • 6.2. COMPARATIVE ANALYSIS ACROSS MARKET SEGMENTS
  • 6.3. OPPORTUNITY MATRIX
  • 6.4. GLOBAL E-PRESCRIBING MARKET BY REGION 2014-2023 ($ MILLION)
    • 6.4.1. NORTH AMERICA
      • 6.4.1.1. INDUSTRIAL END USER ANALYSIS 2014-2023 ($ MILLION)
      • 6.4.1.2. TOP COUNTRY ANALYSIS
        • 6.4.1.2.1. U.S.
          • 6.4.1.2.1.1. MARKET ESTIMATIONS AND FORECASTS 2014-2023 ($ MILLION)
          • 6.4.1.2.1.2. TOP PLAYERS & KEY PRODUCTS
          • 6.4.1.2.1.3. KEY CONCLUSIONS
        • 6.4.1.2.2. CANADA
          • 6.4.1.2.2.1. MARKET ESTIMATIONS AND FORECASTS 2014-2023 ($ MILLION)
          • 6.4.1.2.2.2. TOP PLAYERS & KEY PRODUCTS
          • 6.4.1.2.2.3. KEY CONCLUSIONS
    • 6.4.2. EUROPE
      • 6.4.2.1. INDUSTRY END USER ANALYSIS 2014-2023 ($ MILLION)
      • 6.4.2.2. TOP COUNTRY ANALYSIS
        • 6.4.2.2.1. UK
          • 6.4.2.2.1.1. MARKET ESTIMATIONS AND FORECASTS 2014-2023 ($ MILLION)
          • 6.4.2.2.1.2. TOP PLAYERS & KEY PRODUCTS
          • 6.4.2.2.1.3. KEY CONCLUSIONS
        • 6.4.2.2.2. FRANCE
          • 6.4.2.2.2.1. MARKET ESTIMATIONS AND FORECASTS 2014-2023 ($ MILLION)
          • 6.4.2.2.2.2. TOP PLAYERS & KEY PRODUCTS
          • 6.4.2.2.2.3. KEY CONCLUSIONS
        • 6.4.2.2.3. GERMANY
          • 6.4.2.2.3.1. MARKET ESTIMATIONS AND FORECASTS 2014-2023 ($ MILLION)
          • 6.4.2.2.3.2. TOP PLAYERS & KEY PRODUCTS
          • 6.4.2.2.3.3. KEY CONCLUSIONS
        • 6.4.2.2.4. SPAIN
          • 6.4.2.2.4.1. MARKET ESTIMATIONS AND FORECASTS 2014-2023 ($ MILLION)
          • 6.4.2.2.4.2. TOP PLAYERS & KEY PRODUCTS
          • 6.4.2.2.4.3. KEY CONCLUSIONS
        • 6.4.2.2.5. REST OF EUROPE
          • 6.4.2.2.5.1. MARKET ESTIMATIONS AND FORECASTS 2014-2023 ($ MILLION)
          • 6.4.2.2.5.2. TOP PLAYERS & KEY PRODUCTS
          • 6.4.2.2.5.3. KEY CONCLUSIONS
    • 6.4.3. ASIA PACIFIC
      • 6.4.3.1. INDUSTRY END USER ANALYSIS 2014-2023 ($ MILLION)
      • 6.4.3.2. TOP COUNTRY ANALYSIS
        • 6.4.3.2.1. CHINA
          • 6.4.3.2.1.1. MARKET ESTIMATIONS AND FORECASTS 2014-2023 ($ MILLION)
          • 6.4.3.2.1.2. TOP PLAYERS & KEY PRODUCTS
          • 6.4.3.2.1.3. KEY CONCLUSIONS
        • 6.4.3.2.2. INDIA
          • 6.4.3.2.2.1. MARKET ESTIMATIONS AND FORECASTS 2014-2023 ($ MILLION)
          • 6.4.3.2.2.2. TOP PLAYERS & KEY PRODUCTS
          • 6.4.3.2.2.3. KEY CONCLUSIONS
        • 6.4.3.2.3. JAPAN
          • 6.4.3.2.3.1. MARKET ESTIMATIONS AND FORECASTS 2014-2023 ($ MILLION)
          • 6.4.3.2.3.2. TOP PLAYERS & KEY PRODUCTS
          • 6.4.3.2.3.3. KEY CONCLUSIONS
        • 6.4.3.2.4. AUSTRALIA
          • 6.4.3.2.4.1. MARKET ESTIMATIONS AND FORECASTS 2014-2023 ($ MILLION)
          • 6.4.3.2.4.2. TOP PLAYERS & KEY PRODUCTS
          • 6.4.3.2.4.3. KEY CONCLUSIONS
        • 6.4.3.2.5. REST OF ASIA PACIFIC
          • 6.4.3.2.5.1. MARKET ESTIMATIONS AND FORECASTS 2014-2023 ($ MILLION)
          • 6.4.3.2.5.2. TOP PLAYERS & KEY PRODUCTS
          • 6.4.3.2.5.3. KEY CONCLUSIONS
    • 6.4.4. ROW
      • 6.4.4.1. INDUSTRY END USER ANALYSIS 2014-2023 ($ MILLION)
      • 6.4.4.2. TOP COUNTRY ANALYSIS
        • 6.4.4.2.1. LATIN AMERICA
          • 6.4.4.2.1.1. MARKET ESTIMATIONS AND FORECASTS 2014-2023 ($ MILLION)
          • 6.4.4.2.1.2. TOP PLAYERS & KEY PRODUCTS
          • 6.4.4.2.1.3. KEY CONCLUSIONS
        • 6.4.4.2.2. MIDDLE EAST & AFRICA
          • 6.4.4.2.2.1. MARKET ESTIMATIONS AND FORECASTS 2014-2023 ($ MILLION)
          • 6.4.4.2.2.2. TOP PLAYERS & KEY PRODUCTS
          • 6.4.4.2.2.3. KEY CONCLUSIONS

7. COMPANY PROFILES

  • 7.1. ALLSCRIPTS HEALTHCARE SOLUTIONS INC.
    • 7.1.1. OVERVIEW
    • 7.1.2. PRODUCT PORTFOLIO
    • 7.1.3. KEY INNOVATION SECTOR
    • 7.1.4. STRATEGIC INITIATIVES
    • 7.1.5. SCOT ANALYSIS
    • 7.1.6. STRATEGIC ANALYSIS
  • 7.2. ATHENA HEALTH INC.
    • 7.2.1. OVERVIEW
    • 7.2.2. PRODUCT PORTFOLIO
    • 7.2.3. KEY INNOVATION SECTOR
    • 7.2.4. STRATEGIC INITIATIVES
    • 7.2.5. SCOT ANALYSIS
    • 7.2.6. STRATEGIC ANALYSIS
  • 7.3. CERNER CORPORATION
    • 7.3.1. OVERVIEW
    • 7.3.2. PRODUCT PORTFOLIO
    • 7.3.3. KEY INNOVATION SECTOR
    • 7.3.4. STRATEGIC INITIATIVES
    • 7.3.5. SCOT ANALYSIS
    • 7.3.6. STRATEGIC ANALYSIS
  • 7.4. DRFIRST
    • 7.4.1. OVERVIEW
    • 7.4.2. PRODUCT PORTFOLIO
    • 7.4.3. KEY INNOVATION SECTOR
    • 7.4.4. STRATEGIC INITIATIVES
    • 7.4.5. SCOT ANALYSIS
    • 7.4.6. STRATEGIC ANALYSIS
  • 7.5. DUO SECURITY
    • 7.5.1. OVERVIEW
    • 7.5.2. PRODUCT PORTFOLIO
    • 7.5.3. KEY INNOVATION SECTOR
    • 7.5.4. STRATEGIC INITIATIVES
    • 7.5.5. SCOT ANALYSIS
    • 7.5.6. STRATEGIC ANALYSIS
  • 7.6. ECLINICAL WORKS
    • 7.6.1. OVERVIEW
    • 7.6.2. PRODUCT PORTFOLIO
    • 7.6.3. KEY INNOVATION SECTOR
    • 7.6.4. STRATEGIC INITIATIVES
    • 7.6.5. SCOT ANALYSIS
    • 7.6.6. STRATEGIC ANALYSIS
  • 7.7. E-MDS
    • 7.7.1. OVERVIEW
    • 7.7.2. PRODUCT PORTFOLIO
    • 7.7.3. KEY INNOVATION SECTOR
    • 7.7.4. STRATEGIC INITIATIVES
    • 7.7.5. SCOT ANALYSIS
    • 7.7.6. STRATEGIC ANALYSIS
  • 7.8. GE HEALTHCARE
    • 7.8.1. OVERVIEW
    • 7.8.2. PRODUCT PORTFOLIO
    • 7.8.3. KEY INNOVATION SECTOR
    • 7.8.4. STRATEGIC INITIATIVES
    • 7.8.5. SCOT ANALYSIS
    • 7.8.6. STRATEGIC ANALYSIS
  • 7.9. HENRY SCHEIN INC.
    • 7.9.1. OVERVIEW
    • 7.9.2. PRODUCT PORTFOLIO
    • 7.9.3. KEY INNOVATION SECTOR
    • 7.9.4. STRATEGIC INITIATIVES
    • 7.9.5. SCOT ANALYSIS
    • 7.9.6. STRATEGIC ANALYSIS
  • 7.10. IBM
    • 7.10.1. OVERVIEW
    • 7.10.2. PRODUCT PORTFOLIO
    • 7.10.3. KEY INNOVATION SECTOR
    • 7.10.4. STRATEGIC INITIATIVES
    • 7.10.5. SCOT ANALYSIS
    • 7.10.6. STRATEGIC ANALYSIS
  • 7.11. IMEDX INC.
    • 7.11.1. OVERVIEW
    • 7.11.2. PRODUCT PORTFOLIO
    • 7.11.3. KEY INNOVATION SECTOR
    • 7.11.4. STRATEGIC INITIATIVES
    • 7.11.5. SCOT ANALYSIS
    • 7.11.6. STRATEGIC ANALYSIS
  • 7.12. INFOSYS
    • 7.12.1. OVERVIEW
    • 7.12.2. PRODUCT PORTFOLIO
    • 7.12.3. KEY INNOVATION SECTOR
    • 7.12.4. STRATEGIC INITIATIVES
    • 7.12.5. SCOT ANALYSIS
    • 7.12.6. STRATEGIC ANALYSIS
  • 7.13. PRACTICE FUSION
    • 7.13.1. OVERVIEW
    • 7.13.2. PRODUCT PORTFOLIO
    • 7.13.3. KEY INNOVATION SECTOR
    • 7.13.4. STRATEGIC INITIATIVES
    • 7.13.5. SCOT ANALYSIS
    • 7.13.6. STRATEGIC ANALYSIS
  • 7.14. QUADRAMED CORPORATION
    • 7.14.1. OVERVIEW
    • 7.14.2. PRODUCT PORTFOLIO
    • 7.14.3. KEY INNOVATION SECTOR
    • 7.14.4. STRATEGIC INITIATIVES
    • 7.14.5. SCOT ANALYSIS
    • 7.14.6. STRATEGIC ANALYSIS
  • 7.15. RELAY HEALTH LLC
    • 7.15.1. OVERVIEW
    • 7.15.2. PRODUCT PORTFOLIO
    • 7.15.3. KEY INNOVATION SECTOR
    • 7.15.4. STRATEGIC INITIATIVES
    • 7.15.5. SCOT ANALYSIS
    • 7.15.6. STRATEGIC ANALYSIS

LIST OF TABLES

  • 1. GLOBAL E-PRESCRIBING MARKET BY DELIVERY MODEL 2014-2023 ($ MILLION)
  • 2. GLOBAL CLOUD-BASED E-PRESCRIBING BY GEOGRAPHY 2014-2023 ($ MILLION)
  • 3. GLOBAL ON-PREMISE E-PRESCRIBING BY GEOGRAPHY 2014-2023 ($ MILLION)
  • 4. GLOBAL WEB-BASED E-PRESCRIBING BY GEOGRAPHY 2014-2023 ($ MILLION)
  • 5. GLOBAL E-PRESCRIBING MARKET BY END USER 2014-2023 ($ MILLION)
  • 6. GLOBAL HOSPITALS E-PRESCRIBING BY GEOGRAPHY 2014-2023 ($ MILLION)
  • 7. GLOBAL PHYSICIANS E-PRESCRIBING BY GEOGRAPHY 2014-2023 ($ MILLION)
  • 8. GLOBAL CLINICS E-PRESCRIBING BY GEOGRAPHY 2014-2023 ($ MILLION)
  • 9. GLOBAL E-PRESCRIBING MARKET BY PRODUCT 2014-2023 ($ MILLION)
  • 10. GLOBAL E-PRESCRIBING SOLUTIONS BY GEOGRAPHY 2014-2023 ($ MILLION)
  • 11. GLOBAL E-PRESCRIBING SERVICES BY GEOGRAPHY 2014-2023 ($ MILLION)
  • 12. NORTH AMERICA E-PRESCRIBING MARKET 2014-2023 ($ MILLION)
  • 13. EUROPE E-PRESCRIBING MARKET 2014-2023 ($ MILLION)
  • 14. ASIA PACIFIC E-PRESCRIBING MARKET 2014-2023 ($ MILLION)
  • 15. REST OF THE WORLD E-PRESCRIBING MARKET 2014-2023 ($ MILLION)

LIST OF FIGURES

  • 1). GLOBAL E-PRESCRIBING MARKET BY CLOUD-BASED 2014-2023 ($ MILLION)
  • 2). GLOBAL E-PRESCRIBING MARKET BY ON-PREMISE 2014-2023 ($ MILLION)
  • 3). GLOBAL E-PRESCRIBING MARKET BY WEB-BASED 2014-2023 ($ MILLION)
  • 4). GLOBAL E-PRESCRIBING MARKET BY HOSPITALS 2014-2023 ($ MILLION)
  • 5). GLOBAL E-PRESCRIBING MARKET BY PHYSICIANS 2014-2023 ($ MILLION)
  • 6). GLOBAL E-PRESCRIBING MARKET BY CLINICS 2014-2023 ($ MILLION)
  • 7). GLOBAL E-PRESCRIBING MARKET BY SOLUTIONS 2014-2023 ($ MILLION)
  • 8). GLOBAL E-PRESCRIBING MARKET BY SERVICES 2014-2023 ($ MILLION)
  • 9). UNITED STATES (U.S.) E-PRESCRIBING MARKET 2014-2023 ($ MILLION)
  • 10). CANADA E-PRESCRIBING MARKET 2014-2023 ($ MILLION)
  • 11). UNITED KINGDOM (UK) E-PRESCRIBING MARKET 2014-2023 ($ MILLION)
  • 12). FRANCE E-PRESCRIBING MARKET 2014-2023 ($ MILLION)
  • 13). GERMANY E-PRESCRIBING MARKET 2014-2023 ($ MILLION)
  • 14). SPAIN E-PRESCRIBING MARKET 2014-2023 ($ MILLION)
  • 15). ROE E-PRESCRIBING MARKET 2014-2023 ($ MILLION)
  • 16). INDIA E-PRESCRIBING MARKET 2014-2023 ($ MILLION)
  • 17). CHINA E-PRESCRIBING MARKET 2014-2023 ($ MILLION)
  • 18). JAPAN E-PRESCRIBING MARKET 2014-2023 ($ MILLION)
  • 19). AUSTRALIA E-PRESCRIBING MARKET 2014-2023 ($ MILLION)
  • 20). ROAPAC E-PRESCRIBING MARKET 2014-2023 ($ MILLION)
  • 21). LATIN AMERICA E-PRESCRIBING MARKET 2014-2023 ($ MILLION)
  • 22). MENA E-PRESCRIBING MARKET 2014-2023 ($ MILLION)
Back to Top